Does Dr. PRINCE ADOMAKO have financial conflicts of interest?

Dr. PRINCE ADOMAKO (MD) has received a total of $131 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $131 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. PRINCE ADOMAKO?

According to CMS Open Payments data, Dr. PRINCE ADOMAKO received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($74), SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US ($44), and ABBVIE ($13).

Does Dr. PRINCE ADOMAKO receive research grants or speaking fees?

Dr. PRINCE ADOMAKO has received $131 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. PRINCE ADOMAKO

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: EAST LIVERPOOL, OH 43920

NPI Number: 1073179305

LIFETIME INDUSTRY VALUE

$131

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADOMAKO is a verified Internal Medicine practitioner based in EAST LIVERPOOL, OH.

Between 2021 and 2024, Dr. ADOMAKO had an overall industry promotional and research financial footprint of $131 as recorded in the federal CMS Open Payments database.

$131 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADOMAKO's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $74 (representing 56.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$74

56.6%

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US

Rank 2

$44

33.7%

ABBVIE

Rank 3

$13

9.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.